Cataract Surgery

>

Latest News

Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300

November 20th 2024

Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for procedural sedation during cataract surgery. The results support a regulatory submission, with potential to revolutionize sedation practices in various medical specialties.

Mazava Project shines light on blindness in Madagascar
Mazava Project shines light on blindness in Madagascar

November 16th 2024

HelpMeSee launches global effort to combat cataract blindness and empower women in low-income countries
HelpMeSee launches global effort to combat cataract blindness and empower women in low-income countries

November 14th 2024

HelpMeSee teaming up with Empowered with Meg Ryan to highlight solutions for global cataract blindness crisis in new episode
HelpMeSee teaming up with Empowered with Meg Ryan to highlight solutions for global cataract blindness crisis in new episode

November 14th 2024

Study explores the true costs of treating pediatric cataracts
Study explores the true costs of treating pediatric cataracts

November 12th 2024

Video Interviews
Podcasts
EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
EyePod: Transforming the MIGS pipeline into clinical practice
EYEPOD: Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

More News

© 2024 MJH Life Sciences

All rights reserved.